(Recasts, adds analyst comment, details and CFO comment) By Amina Niasse and Kunal Das Nov 9 (Reuters) – Hims & Hers Health said on Monday it will begin offering some unapproved peptide treatments in
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nov 10 (Reuters) - Nanoveu Ltd: * UNIT SIGNS DIGIKEY AS GLOBAL DISTRIBUTOR FOR ECS-DOT-22…
By Echo Wang Nov 9 (Reuters) - Anthropic is aiming to raise as much as…
Nov 10 (Reuters) - New Age Exploration Ltd: * ADVISED THAT COMPANY WAS REMOVED FROM…
By Courtney Rozen WASHINGTON, Nov 9 (Reuters) - US President Donald Trump's close relationship with…
By Courtney Rozen WASHINGTON, Nov 9 (Reuters) - US President Donald Trump's close relationship with…
By Reuters Fact Check (The article has been published through a syndicated feed. Except for…